arm

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…

3 weeks ago

MEXC IgniteX Partners with Superteam to Launch Revolutionary “IgniteX Solana Talent Lab” at Solana Summit APAC

VICTORIA, Seychelles, June 5, 2025 /PRNewswire/ -- MEXC IgniteX, the $30 million global CSR initiative and innovation arm of MEXC Ventures,…

4 weeks ago